Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2012
07/26/2012US20120189546 Radiolabelling Method Using Cycloalkyl Groups
07/26/2012CA2825367A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012CA2825308A1 Pyrazolopyrimidone compound for treating erectile dysfunction
07/26/2012CA2824873A1 Bicyclic carboxamide inhibitors of kinases
07/25/2012EP2479177A1 Process for the preparation of antibiotic compounds
07/25/2012EP2477991A1 Process for preparing azabicyclic compounds
07/25/2012EP2477967A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
07/25/2012EP2477628A1 Preparation of crystalline forms of dihydropyrazolopyrimidinone
07/25/2012EP2220091B1 Reverse transcriptase inhibitors
07/25/2012EP2118110B1 Cyclopropyl fused indolobenzazepine hcv inhibitors
07/25/2012EP1956022B1 Compound for organic electroluminescent element and organic electroluminescent element
07/25/2012EP1934222B1 Pyrazolo[1, 5 -alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
07/25/2012EP1270557B1 Ethylenediamine derivatives
07/25/2012EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
07/25/2012CN102603753A Isomers of hemoporfin
07/25/2012CN102603752A 7-bromopyrazolo[1,5-alpha]pyridine-3-formic ether compound and synthetic method and application thereof
07/25/2012CN102603751A Triazol (4,5-D) pyrimidine derivate and preparation method of triazol (4,5-D) pyrimidine derivate as well as application of triazol (4,5-D) pyrimidine derivate in drug preparation
07/25/2012CN102603750A Synthesis method of triazolylquinoxalinone derivatives
07/25/2012CN102603749A Synthesis method of sitagliptin intermediate
07/25/2012CN102603748A Carbazole-based high-condensed ring dinitrogen-aza[7]helicene compound and synthetic method thereof
07/25/2012CN102058603B Disubstituted zinc phthalocyanine composite, and preparation method and application thereof
07/25/2012CN101787268B Gel profile control agent for delaying generation of precipitation granules and preparation method thereof
07/25/2012CN101717403B New green synthesizing process for ketocoumaran compound
07/25/2012CN101704819B Purifying method of 3,7-binitro-1,3,5,7-diazabicyclo[3,3,1]nonane
07/25/2012CN101698668B Crystal form V of Aildenafil citrate and preparation method and application thereof
07/25/2012CN101671338B Citric acid alidenafil crystal form D and preparation method and usage thereof
07/25/2012CN101475573B Anti-influenza medicament Tamiflu intermediate, synthesizing method and use thereof
07/25/2012CN101405240B Reagent for organic synthesis and method of organic synthesis reaction with the reagent
07/25/2012CN101137606B Process for oxidation of organic compounds
07/24/2012US8227619 Process for the preparation of amides
07/24/2012US8227601 Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV
07/24/2012US8227475 Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
07/24/2012US8227472 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
07/24/2012US8227458 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
07/24/2012CA2690483C The use of anti-histaminics for acute reduction of elevated intracranial pressure
07/19/2012WO2012097196A1 Pyrazolopyrimidine derivatives and uses as anticancer agents
07/19/2012WO2012096929A2 Heteroaryl compounds and methods of use thereof
07/19/2012WO2012095781A1 Indazole derivatives as sodium channel inhibitors
07/19/2012WO2012095469A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders
07/19/2012WO2012095143A1 Compounds for organic electroluminescent devices
07/19/2012WO2012095142A1 5-([1,2,3]triazole-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
07/19/2012WO2012094966A1 3-aryl-6-aryl-[1,2,4]triazolo[4,3-b]pyridazine as cell proliferation inhibiting agent and use thereof
07/19/2012WO2012070015A9 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
07/19/2012WO2012048164A3 Porphyrin treatment of neurodegenerative diseases
07/19/2012WO2012035489A9 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
07/19/2012US20120184567 Inhibitors of bruton's tyrosine kinase
07/19/2012US20120184558 Crystalline Salt Forms of a 5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3-a]Pyrazine Derivative
07/19/2012US20120184557 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
07/19/2012US20120184546 [1,2,4]triazolo [1,5-c]pyrimidine derivatives as hsp90 modulators
07/19/2012US20120184536 Compositions comprising specific ugt inhibitors and methods of use thereof
07/19/2012US20120184530 Dimeric IAP Inhibitors
07/19/2012US20120184508 Pyrazolo pyrimidines
07/19/2012US20120183954 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183496 Inhibitors of hepatitis c virus polymerase
07/19/2012CA2824293A1 5-(1,2,3-triazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
07/19/2012CA2824220A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders
07/19/2012CA2824047A1 Heteroaryl compounds and methods of use thereof
07/18/2012EP2476701A1 Antimicrobial agents based on hemin derivatives
07/18/2012EP2476683A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
07/18/2012EP2476681A2 Amino-aza-adamantane derivatives and methods of use
07/18/2012EP2476679A2 Substituted triazoles useful as AXL inhibitors
07/18/2012EP2475668A1 Ether derivatives of bicyclic heteroaryls
07/18/2012EP2475667A1 Inhibitors of jak
07/18/2012EP2475666A2 Gyrase inhibitors
07/18/2012EP2475665A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS
07/18/2012EP2475664A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475662A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475657A1 Inhibitors of flaviviridae viruses
07/18/2012EP2475650A1 Furan derivative and electrophotographic photoconductor
07/18/2012EP2475256A1 Hepatitis c virus inhibitors
07/18/2012EP2475254A1 Hepatitis c virus inhibitors
07/18/2012EP1999132B1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
07/18/2012EP1608648B1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
07/18/2012CN1951917B Pyridinone derivatives for treatment of atherosclerosis
07/18/2012CN1639130B Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
07/18/2012CN1443167B Azacyclic compounds for use in treatment of 5-serotonin related diseases
07/18/2012CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/18/2012CN102598344A Organic electroluminescent element
07/18/2012CN102596966A Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound
07/18/2012CN102596965A Pyrrolo [3,2-E] [1,2,4] triazolo [1,5-A] pyrimidines derivatives as inhibitors of microglia activation
07/18/2012CN102596964A Pyrrolo [3,2-E] [1,2,4] triazolo [1,5-A] pyrimidines derivatives as inhibitors of microglia activation
07/18/2012CN102596963A Ether derivatives of bicyclic heteroaryls
07/18/2012CN102596962A Inhibitors of JAK
07/18/2012CN102596961A Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
07/18/2012CN102596960A Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
07/18/2012CN102596959A Pyrrolo [1, 2-b] pyridazine derivatives as JANUS kinase inhibitors
07/18/2012CN102596958A 2' -fluoro substituted CARBA-nucleoside analogs for antiviral treatment
07/18/2012CN102596957A Substituted pyrazolo[1,5- a]pyrimidine compounds as TRK kinase inhibitors
07/18/2012CN102596955A Histamine H3 inverse agonists and antagonists and methods of use thereof
07/18/2012CN102596950A Deuterated compounds for electronic applications
07/18/2012CN102596932A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
07/18/2012CN102596857A Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects
07/18/2012CN102584842A Preparation of substituted indole lactam derivative and application of substituted indole lactam derivative as antimalarial agent
07/18/2012CN102584839A Preparation process of deuterohemin
07/18/2012CN102584838A Natural ferrous aluminum chlorophyll and preparation method thereof
07/18/2012CN102584837A Natural chlorophyl ferro-chromo-lignosulfonate and preparation method
07/18/2012CN102584836A Porphyrin cage compound, and preparation method and application thereof
07/18/2012CN102584835A Spiral heterocyclic compound containing indole structure and method for preparing same
07/18/2012CN102584834A Separation method for mixture of triethylene-diamine and ethanolamine
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 573